Life Sciences Opportunities in India & China: From Innovation to Commercialization
30 September 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
01 May 2024
Article
DOJ and FTC Raise Concerns about Overlapping Ownership in Public Utility Companies
On April 25, 2024, the U.S. Department of Justice Antitrust Division and the Federal Trade Commission filed a joint comment with the Federal Energy Regulatory Commission raising concerns about FERC’s blanket authorization policy, which, among other things, allows holding companies, including investment companies, to acquire noncontrolling ownership interests in public utility companies, subject to certain conditions.
22 May 2024
Events
May 2024 Midwest Cyber Security Alliance Meeting | Integrating Trending AI and CMMC Compliance Into Vendor Management
Join us on Wednesday, May 22, 2024, at the next Midwest Cyber Security Alliance meeting, where sponsor Sikich LLP, along with Foley attorneys Chanley Howell and Leighton Allen, will delve into the integration of two critical components — AI due diligence and Cybersecurity Maturity Model Certification (CMMC) compliance — to fortify vendor management practices.
16 May 2024
Events
Litigating Patent Claims at the ITC and How It Could Impact Your Company
The U.S. International Trade Commission is a fast-paced, high-stakes forum empowered by Section 337 of the U.S. Tariff Act to hear and resolve patent infringement complaints brought by companies against acts in the importation of products.